Thromb Haemost 1999; 82(05): 1433-1436
DOI: 10.1055/s-0037-1614850
Rapid Communications
Schattauer GmbH

Elevated Levels of sE-selectin in Post-menopausal Females Are Decreased by Hormone Replacement Therapy to Levels Observed in Pre-menopausal Females

Gwen Kennedy
2   National Heart and Lung Institute, Imperial College School of Medicine, Charing Cross Hospital, London, UK
,
Margaret McLaren
2   National Heart and Lung Institute, Imperial College School of Medicine, Charing Cross Hospital, London, UK
,
Jill J. F. Belch
2   National Heart and Lung Institute, Imperial College School of Medicine, Charing Cross Hospital, London, UK
,
Mary Seed
1   From the Section of Vascular Medicine and Biology, University Department of Medicine, Ninewells Hospital & Medical School, Dundee, and the National Heart and Lung Institute, Imperial College School of Medicine, Charing Cross Hospital, London, UK
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 06. November 1998

Accepted after resubmission 07. Juli 1999

Publikationsdatum:
09. Dezember 2017 (online)

Preview

Summary

Observational epidemological studies have shown that mortality from coronary heart disease is reduced in post-menopausal women by hormone replacement therapy (HRT). The aim of this study was to measure sE-selectin levels in post-menopausal females before and after HRT and to compare these with pre-menopausal females and aged matched males. Post-menopausal females (n = 70) were given HRT or no treatment to act as a control group. sE-selectin levels were significantly lower in the pre-menopausal (n = 36) when compared with the post-menopausal females (n = 70) (p = 0.027), whereas no difference between two age matched male groups was found (n = 40). Oral and transdermal HRT significantly decreased sE-selectin levels (p <0.0001 and p = 0.0005 respectively) with no change in the control group. The reduction in the levels of this marker of endothelial activation after HRT, may reflect a decrease in leucocyte/endothelial interaction which may reduce atherosclerotic risk in post-menopausal females.